We manage people’s money, and we also make investments of our own. This means we have the influence to drive changes on a bigger scale, to work towards a more positive future for everyone.
Our planet is constantly changing, driven by both environmental and societal revolution and evolution. And the global impact of COVID-19 has demonstrated how quickly our own world can be reshaped. We are all on this journey together.
Creating a brighter future, together
We all want to create a brighter future for the next generation. At M&G our mission is to help fix the planet one investment at a time - aiming to achieve long-term financial returns for our customers while making a positive impact on the world around us. It’s a big idea, but it's the longer-term financial decisions, as well as the day-to-day choices you make, that have the potential to make a positive impact on a global scale.
M&G has a wide range of funds, including impact and sustainable funds, all with their individual aims and objectives. The M&G Positive Impact Fund and the M&G Sustainable Multi Asset Fund are two such funds with the specific aim of achieving long-term financial returns while investing to achieve something better, for people, for communities, and for the planet.
Read our Annual Impact Report for the M&G Positive Impact Fund to discover how, with the help of our investors, we're driving towards environmental and societal change, one investment at a time.
How do we make a positive impact through our investments?
Here's an example of one of the companies we have invested in, providing solutions for one of our planet's greatest challenges.
Building a better future with ALK-Abelló
Allergic disease is one of the world’s most common chronic conditions, affecting millions of people globally. Hay fever alone affects an estimated 400-500 million people worldwide, approximately 10% of whom experience a debilitating form of the condition. Left untreated, allergic rhinitis is considered to be a major risk for the development of asthma.
ALK-Abelló is a pharmaceutical company that specialises in developing products for more than 500 million people worldwide who suffer from allergies. Its roots go back nearly 100 years to 1923 and ever since then the company has been working to improve the treatment of allergy patients, whose disease can severely affect their quality of life.
Among its innovations have been immunotherapy tablets against some of the most common respiratory allergies – including grass pollen and house dust mites – that allow allergy patients to self-administer from the comfort of their own home, rather than suffering painful injections in a clinical setting. Innovations like this can positively transform lives, helping realise Goal 3 of the United Nations Sustainable Development Goals.
To read more about how ALK is making a positive impact on the world’s health visit their website.
Understanding sustainable multi asset investing
Click here to read a transcript of the video
The value of any fund's assets will go down as well as up. This will cause the value of your investment to fall as well as rise and you may get back less than you originally invested.
Please view our glossary for explanations of investment terms you are not familiar with.